Delayed symptomatic hemobilia after ultrasound-guided liver biopsy: a case report.
The incidence of hemobilia following percutaneous liver biopsy ranges between 0 and 1%. It is an unpredictable complication and the lack of symptoms or delay in their presentation further complicates its diagnosis. We report a case of hemobilia after US-guided percutaneous liver biopsy for diffuse HCV-related liver disease. The diagnosis of hemobilia was established 6 days after the percutaneous liver biopsy by endoscopic retrograde cholangiopancreatography. After superselective catheterization of the feeding artery, vascular occlusion was successfully obtained with gel foam pledges and the patient was discharged 7 days after the procedure.
Rossi
Piero
P
Department of Surgery, Department of Infectious Diseases, University of Rome Tor Vergata, Clinica Columbus, Rome, Italy.
Sileri
Pierpaolo
P
Gentileschi
Paolo
P
Sica
Giuseppe S
GS
Ercoli
Lucia
L
Coscarella
Giorgio
G
De Majo
Adriano
A
Gaspari
Achille L
AL
D000328:Adult; D001707:Biopsy, Needle / Q000009:adverse effects*; D002760:Cholangiopancreatography, Endoscopic Retrograde; D004621:Embolization, Therapeutic; D005260:Female; D006431:Hemobilia / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006499:Hepatic Artery / Q000000981:diagnostic imaging; D006801:Humans; D008107:Liver Diseases / Q000000981:diagnostic imaging / Q000473:pathology*; D008111:Liver Function Tests; D014463:Ultrasonography